Diminutio

“I didn’t want to meet you.” Dispelling myths about palliative care


 

The names of health care professionals and patients cited within the dialogue text have been changed to protect their privacy.

Early in my career, before I had any notion that years later I would be doing palliative care consults in a cancer center, I heard a senior physician refer to palliative care as “the most misunderstood” medical specialty. I wasn’t sure what she meant at that time, but over the years I have come to realize that she was right – most people, including many within health care, don’t have a good appreciation of what palliative care is or how it can help patients and health care teams.

Sarah F. D'Ambruoso, a nurse practitioner at Santa Monica (Calif.) Cancer Care in the UCLA Health System

Sarah F. D'Ambruoso, NP

A recent national survey about cancer-related health information found that of more than 1,000 surveyed Americans, less than 30% professed any knowledge of palliative care. Of those who had some knowledge of palliative care, around 30% believed palliative care was synonymous with hospice.1 Another 15% believed that a patient would have to give up cancer-directed treatments to receive palliative care.1

It’s not giving up

This persistent belief that palliative care is equivalent to hospice, or is tantamount to “giving up,” is one of the most commonly held myths I encounter in everyday practice.

I knock on the exam door and walk in.
A small, trim woman in her late 50s is sitting in a chair, arms folded across her chest, face drawn in.

“Hi,” I start. “I’m Sarah, the palliative care nurse practitioner who works in this clinic. I work closely with Dr. Smith.”
Dr. Smith is the patient’s oncologist.

“I really didn’t want to meet you,” she says in a quiet voice, her eyes large with concern.

I don’t take it personally. Few patients really want to be in the position of needing to meet the palliative care team.

“I looked up palliative care on Google and saw the word hospice.”

“Yeah,” I say. “I hear that a lot. Well, I can reassure you that this isn’t hospice.
In this clinic, our focus is on your cancer symptoms, your treatment side effects, and your quality of life.”

She looks visibly relieved. “Quality of life,” she echoes. “I need more of that.”
“OK,” I say. “So, tell me what you’re struggling with the most right now.”

That’s how many palliative care visits start. I actually prefer if patients haven’t heard of palliative care because it allows me to frame it for them, rather than having to start by addressing a myth or a prior negative experience. Even when patients haven’t had a negative experience with palliative care per se, typically, if they’ve interacted with palliative care in the past, it’s usually because someone they loved died in a hospital setting and it is the memory of that terrible loss that becomes synonymous with their recollection of palliative care.

Many patients I meet have never seen another outpatient palliative care practitioner – and this makes sense – we are still too few and far between. Most established palliative care teams are hospital based and many patients seen in the community do not have easy access to palliative care teams where they receive oncologic care.2 As an embedded practitioner, I see patients in the same exam rooms and infusion centers where they receive their cancer therapies, so I’m effectively woven into the fabric of their oncology experience. Just being there in the cancer center allows me to be in the right place at the right time for the right patients and their care teams.

Pages

Recommended Reading

25% of patients with cancer lack immunity against measles
MDedge Hematology and Oncology
NCCN recommends third COVID-19 dose for patients with cancer
MDedge Hematology and Oncology
‘Locker room talk’ about death: Time for oncologists to stop
MDedge Hematology and Oncology
Tramadol linked to higher risk of mortality, compared with codeine
MDedge Hematology and Oncology
FDA approves combo pill for severe, acute pain
MDedge Hematology and Oncology
ACIP recommends Shingrix for younger immunocompromised adults; updates pneumococcal vaccine guidance
MDedge Hematology and Oncology
Talk early to patients with high-risk AML about end-of-life decisions
MDedge Hematology and Oncology
Delays in cancer referral, diagnosis linked with morbidities
MDedge Hematology and Oncology
Pill not enough for ‘sexual problems’ female cancer patients face
MDedge Hematology and Oncology
Siblings of people with bipolar disorder have higher cancer risk
MDedge Hematology and Oncology